Paul Friedman
Chairman chez PRELUDE THERAPEUTICS INCORPORATED
Fortune : 225 M $ au 29/02/2024
Profil
Paul A. Friedman est un homme d'affaires qui a été à la tête de 5 entreprises différentes et qui occupe actuellement le poste de président du conseil d'administration de Prelude Therapeutics, Inc. et de président, président et chef de la direction de Madrigal Pharmaceuticals, Inc. Paul A. Friedman est également membre du conseil d'administration d'Incyte Corp. (ancien président, directeur général et administrateur), d'Alexion Pharmaceuticals, Inc. et de Gliknik, Inc. et membre de l'American Society for Clinical Investigation, membre de l'American Society for Biochemistry & Molecular Biology, Inc. et membre de l'American Society for Pharmacology & Experimental Therapeutic. Paul A. Friedman a précédemment occupé les postes de directeur chez Cerulean Pharma, Inc, président des laboratoires de recherche de DuPont Pharmaceuticals, président de la recherche et du développement chez DuPont Merck Pharmaceutical Co, premier vice-président de Merck Research Laboratories Massachusetts LLC et professeur associé de médecine et de pharmacologie à la Harvard Medical School. Le Dr Friedman a obtenu un diplôme de premier cycle de l'Université de Princeton et un doctorat de la Harvard Medical School.
Détentions connues dans des sociétés publiques
Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
---|---|---|---|---|
31/03/2023 | 944 226 ( 4,78% ) | 223 M $ | 29/02/2024 | |
16/06/2023 | 510 474 ( 0,93% ) | 2 M $ | 29/02/2024 |
Postes actifs de Paul Friedman
Sociétés | Poste | Début |
---|---|---|
MADRIGAL PHARMACEUTICALS, INC. | Director/Board Member | 15/06/2023 |
PRELUDE THERAPEUTICS INCORPORATED | Chairman | - |
American Society for Biochemistry & Molecular Biology, Inc.
American Society for Biochemistry & Molecular Biology, Inc. Miscellaneous Commercial ServicesCommercial Services The American Society for Biochemistry and Molecular Biology, Inc. is an international non-profit scientific and educational organization based in Bethesda, MD. With over 11,000 members, the society is one of the largest molecular life science societies in the world. The society serves the scientific community through the publication of peer-reviewed journals and science news, organization of scientific meetings, advocacy for funding of basic research and education, support of career development and science education at all levels, promoting the diversity of individuals entering the scientific workforce, and celebrating important contributions and achievements in science and technology made by black scientists. The society also honors an outstanding scientist who has shown a sustained commitment to breaking down local and/or systemic barriers against scientists and students from historically marginalized or excluded groups. Founded in 1906, the society's mission is to advance the science of biochemistry and molecular biology and promote the understanding of the molecular nature of life processes. | Corporate Officer/Principal | 29/05/2009 |
American Society for Pharmacology & Experimental Therapeutic | Corporate Officer/Principal | 29/05/2009 |
American Society for Clinical Investigation
American Society for Clinical Investigation BiotechnologyHealth Technology American Society for Clinical Investigation engages as a medical honor society. It focuses on physician-scientists in research, clinical care, and medical education. The company was founded by Samuel J. Meltzer in 1908 and is headquartered in Ann Arbor, MI. | Corporate Officer/Principal | - |
Anciens postes connus de Paul Friedman
Sociétés | Poste | Fin |
---|---|---|
ALEXION PHARMACEUTICALS, INC. | Director/Board Member | 14/07/2021 |
INCYTE CORPORATION | Chief Executive Officer | 13/11/2014 |
VERASTEM, INC. | Director/Board Member | 27/04/2017 |
Cerulean Pharma, Inc.
Cerulean Pharma, Inc. Pharmaceuticals: MajorHealth Technology Cerulean Pharma, Inc. is a clinical-stage, oncology-focused company, which provides proprietary Dynamic Tumor Targeting Platform to develop differentiated therapies. It specializes in the design and development of nanopharmaceuticals. Cerulean's nanopharmaceuticals are drug-containing nanoparticles designed and optimized to enhance therapeutic agents, ranging from small molecules to therapeutic peptides and RNAi molecules. The company was founded by Alan L. Crane and Ram Sasisekharn on November 28, 2005 and is headquartered in Waltham, MA. | Chairman | 30/06/2016 |
░░░░░ ░░░░░░░░░░░░░░░ ░░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ |
Formation de Paul Friedman
Princeton University | Undergraduate Degree |
Harvard Medical School | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
Sociétés cotées | 4 |
---|---|
INCYTE CORPORATION | Health Technology |
VERASTEM, INC. | Health Technology |
PRELUDE THERAPEUTICS INCORPORATED | Health Technology |
MADRIGAL PHARMACEUTICALS, INC. | Health Technology |
Entreprise privées | 15 |
---|---|
Bausch & Lomb, Inc.
Bausch & Lomb, Inc. Medical SpecialtiesHealth Technology Bausch & Lomb, Inc. develops, manufactures, and markets eye health products. It offers over-the-counter supplements, eye care products, ophthalmic pharmaceuticals, contact lenses, lens care, ophthalmic surgical devices, and instruments. The company was founded by John Jacob Bausch and Henry Lomb in 1853 and is headquartered in Rochester, NY. | Health Technology |
Alexion Pharmaceuticals, Inc.
Alexion Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Alexion Pharmaceuticals, Inc. engages in the business of serving patients and families affected by rare diseases and devastating conditions through the discovery, development, and commercialization of life-changing medicines. The firm also focuses on the development of haematology, nephrology, neurology, metabolic disorders, cardiology, and ophthalmology. The company was founded by Joseph A. Madri, David W. Keiser, Stephen P. Squinto, and Leonard Bell in January 1992 and is headquartered in Boston, MA. | Health Technology |
Auxilium Pharmaceuticals LLC
Auxilium Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Auxilium Pharmaceuticals LLC develops and markets pharmaceutical products. It specializes in men's healthcare area and has product portfolio and pipeline in orthopedics, dermatology and other therapeutic areas. The firm products include edex, Osbon, ErecAid, STENDRA, TESTOPEL, XIAFLEX and Testim. The company was founded by Gerri A. Henwood and Jane Holmes Hollingsworth in 1999 and is headquartered in Chesterbrook, PA. | Health Technology |
Sirtris Pharmaceuticals, Inc.
Sirtris Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Sirtris Pharmaceuticals, Inc., a GSK company, is developing small molecule drugs that target the sirtuins, a family of seven enzymes associated with diseases of aging. Modulation of these enzymes offers the promise of drug discovery in multiple therapeutic areas. Sirtris was one of the pharmaceutical companies focused on the sirtuin platform and remains the innovative drug discovery. Preclinical research indicates that the sirtuins play important roles in pathways for multiple diseases of aging, including Type 2 Diabetes, as well as neurodegenerative, cardiovascular and inflammatory diseases. Sirtris researchers are working to translate this research into a potential new class of pharmaceuticals to treat diseases of aging, offering the ability for people to live longer, healthier lives. Sirtris has focused on developing many novel small molecule activators of SIRT1, the most studied member of the sirtuin family. These new chemical entities or NCEs are novel compounds that are chemically unrelated to resveratrol, a naturally occurring compound that was used as an early proof-of-concept for SIRT1 activation. Besides being structurally differentiated from resveratrol, the NCEs are more specific for the target SIRT1 and have improved drug-like properties. The company has completed several early stage translational clinical studies with the first generation NCEs and has several active clinical trials under way. Sirtris operates as an independent Discovery Performance Unit (DPU) within GSK and is located in Technology Square, Cambridge, Mass. Sirtris' culture mixes scientific curiosity with a dynamic, fast-paced environment, resembling its biotech roots while harnessing all of GSK's broad discovery, development, and commercialization capabilities. The company was founded in 2004 and is headquartered in Cambridge, MA. | Health Technology |
Synta Pharmaceuticals Corp.
Synta Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Synta Pharmaceuticals Corp. discovers, develops and commercializes pharmaceutical products. It focuses on the research, development and commercialization of oncology medicines that provides treatment to cancer patients. The company is also developing a proprietary platform for delivery of anti-cancer drugs directly to tumor cells, known as Hsp90-inhibitor drug conjugates. Synta Pharmaceuticals was founded by Safi R. Bahcall and Lan-Bo Chen in March 2000 and is headquartered in Lexington, MA. | Health Technology |
Gliknik, Inc.
Gliknik, Inc. Pharmaceuticals: MajorHealth Technology Gliknik, Inc. discovers and develops biotechnology drugs for autoimmune diseases and cancer. The company was founded by David S. Block and Scott E. Strome in 2007 and is headquartered in Baltimore, MD. | Health Technology |
Navitor Pharmaceuticals, Inc.
Navitor Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Navitor Pharmaceuticals, Inc. develops medicine for age-related diseases. Its drug discovery platform targets mTORC1, which responds to and integrates the cell’s response to nutrient availability and plays a key role in protein synthesis and cellular growth. The company was founded by Alan L. Crane, David Sabatini and David Goldfarb and is headquartered in Cambridge, MA. | Health Technology |
DuPont Merck Pharmaceutical Co.
DuPont Merck Pharmaceutical Co. Pharmaceuticals: MajorHealth Technology Part of Corteva, Inc., DuPont Merck Pharmaceutical Co. is a private company that makes pharmaceuticals and drugs. The company is based in Wilmington, DE. DuPont Merck Pharmaceutical was acquired by EIDP, Inc., a subsidiary of Corteva, Inc. from Merck & Co., Inc. on July 01, 1998 for $2,600 million. | Health Technology |
Cerulean Pharma, Inc.
Cerulean Pharma, Inc. Pharmaceuticals: MajorHealth Technology Cerulean Pharma, Inc. is a clinical-stage, oncology-focused company, which provides proprietary Dynamic Tumor Targeting Platform to develop differentiated therapies. It specializes in the design and development of nanopharmaceuticals. Cerulean's nanopharmaceuticals are drug-containing nanoparticles designed and optimized to enhance therapeutic agents, ranging from small molecules to therapeutic peptides and RNAi molecules. The company was founded by Alan L. Crane and Ram Sasisekharn on November 28, 2005 and is headquartered in Waltham, MA. | Health Technology |
American Society for Clinical Investigation
American Society for Clinical Investigation BiotechnologyHealth Technology American Society for Clinical Investigation engages as a medical honor society. It focuses on physician-scientists in research, clinical care, and medical education. The company was founded by Samuel J. Meltzer in 1908 and is headquartered in Ann Arbor, MI. | Health Technology |
Merck Research Laboratories Massachusetts LLC
Merck Research Laboratories Massachusetts LLC Pharmaceuticals: MajorHealth Technology Part of Merck & Co., Inc., Merck Research Laboratories Massachusetts LLC is a pharmaceutical company that provides free medicines and adult vaccines to qualified patients through their Merck Patient Assistance Program. The private company is based in Boston, MA and is a part of Merck & Co., Inc. and its affiliates. The company also offers information about insurance coverage and financial assistance options for eligible patients. The company conducts clinical trials and provides medical information covering thousands of topics in all fields of medicine through their Merck Manuals. Additionally, they report on their commitment to operating responsibly to benefit society through their corporate responsibility program, which includes their environmental, social, and governance (ESG) report. Merck for Mothers is an initiative to create a world where no woman has to die giving life. | Health Technology |
American Society for Biochemistry & Molecular Biology, Inc.
American Society for Biochemistry & Molecular Biology, Inc. Miscellaneous Commercial ServicesCommercial Services The American Society for Biochemistry and Molecular Biology, Inc. is an international non-profit scientific and educational organization based in Bethesda, MD. With over 11,000 members, the society is one of the largest molecular life science societies in the world. The society serves the scientific community through the publication of peer-reviewed journals and science news, organization of scientific meetings, advocacy for funding of basic research and education, support of career development and science education at all levels, promoting the diversity of individuals entering the scientific workforce, and celebrating important contributions and achievements in science and technology made by black scientists. The society also honors an outstanding scientist who has shown a sustained commitment to breaking down local and/or systemic barriers against scientists and students from historically marginalized or excluded groups. Founded in 1906, the society's mission is to advance the science of biochemistry and molecular biology and promote the understanding of the molecular nature of life processes. | Commercial Services |
American Society for Pharmacology & Experimental Therapeutic | |
DuPont Pharmaceuticals Research Laboratories | |
Durata Therapeutics, Inc.
Durata Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Durata Therapeutics, Inc. develops and commercializes novel therapeutics for infectious diseases and acute illnesses. The company was founded on November 4, 2009 and is headquartered in Chicago, IL. | Health Technology |